BREAST CANCER SURVIVAL: A HOSPITAL-BASED STUDY IN REGIONAL CANCER CENTRE, BENGALURU

Author:

C R Vijay1,D Ashalatha2,K Shobha3,Sridhar P4,K Venkatesh5

Affiliation:

1. Associate Professor, Department of Epidemiology and Biostatistics, Kidwai Memorial Institute of Oncology, Bangalore-29.

2. Assistant Professor, Department of Radiation Oncology, Kidwai Memorial Institute of Oncology, Bangalore-29.

3. Associate Professor, Department of Gynaec Oncology, Kidwai Memorial Institute of Oncology, Bangalore-29.

4. Associate Professor, Department of Radiation Oncology, Kidwai Memorial Institute of Oncology, Bangalore-29.

5. Statistical Assistant, Department of Epidemiology and Biostatistics, Kidwai Memorial Institute of Oncology, Bangalore-29.

Abstract

Introduction: Breast cancer is one of the most common cancer among Indian Women. The age adjusted rate (AAR) of Breast cancer is 42.1/100000 women in Bengaluru and it is the leading site of cancer in Bengalurian females. The hospital based cancer registry was established in 1983 and is registering around 800 Breast cancer cases per year. Most of them were diagnosed with late stage. The objective of this study is to evaluate Pattern of Care and estimate the Survival rate with respect to different stages, Treatment modalities, ER, PR, HER-2 Status of breast cancer treated only at Kidwai Cancer Institute. A retrospective cohort study was Methodology carried out with 191 Carcinoma Breast cases at a Regional Cancer Centre (Kidwai Memorial Institute of Oncology), Bengaluru. The study started from 2006-2007 and was followed-up until the end of 2020. Five-year survival (60 Months) probabilities were estimated using the Kaplan-Meier and loss adjusted survival analysis method for less than 80% follow-up group for ten years. The log rank test was used to compare the survival between the factors. The overall observed survival rates at 5years Results (60 months) was 72.7%. When analysis was conducted for specic stages, Stage II, Stage III and Stage IV survival rates are 95%, 67% and 17% respectively and is statistically signicant (p<0.001), 39 Patients were dead and 13 Patients were lost for follow-up. The overall survival rate at 10 years was 62.4% and lost for follow-up was 26.5% and death was 27.7%, the Kaplan Meier analysis was unable to be carried out as more than 20% censored cases were seen, hence loss adjusted survival analysis was carried out for 10 years. 89 Patients were alive, 52 patients were dead and 50 patients were lost for follow-up at 10 years. Conclusion: In surgical histopathological nding Estrogen receptor, Progesterone receptor and HER-2 status did not have signicant impact on survival of patients. The post-operative Radiotherapy and combination of modalities of treatment had signicant effect on the long term survival of the patients after adjusting for disease stage.

Publisher

World Wide Journals

Subject

Safety, Risk, Reliability and Quality,Nuclear Energy and Engineering,General Engineering,General Engineering,Nuclear and High Energy Physics,Nuclear and High Energy Physics,General Energy,Mechanical Engineering,Waste Management and Disposal,Safety, Risk, Reliability and Quality,General Materials Science,Nuclear Energy and Engineering,Nuclear and High Energy Physics,General Engineering,Nuclear Energy and Engineering,Condensed Matter Physics,Nuclear and High Energy Physics

Reference22 articles.

1. Time trend in Cancer Incidence Rates 1982-2010: National Cancer Registry Programme, Indian Council of Medical Research, New Delhi, July 2013.

2. Consolidated Report of the Population Based Cancer Registries 2011-2014. National cancer Registry Programme, Indian Council of Medical Research, New Delhi, July 2015.

3. Annual Report 2013: Kidwai Memorial Institute of Oncology, Bengaluru, 2016.

4. Taylor R, Coates M (1997). Breast cancer five-year survival in New South Wales women 1972 to 1991. Aust NZ J Public Health, 21, 199-205.

5. Ugnat AM, Xie L, Morriss J, Semenciw R, Mao Y (2004). Survival of women with breast Cancer in Ottawa, Canada: variation with age, stage, histology, grade, and treatment. Br J Cancer, 90, 1138-43.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3